Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
890.7 USD | -1.75% | -0.37% | +1.41% |
Apr. 25 | Regeneron Pharmaceuticals Receives a Shareholder Proposal from John Chevedden | CI |
Apr. 25 | Regeneron Sets Crispr-Based Collaboration With Mammoth Biosciences | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.41% | 95.71B | |
-2.26% | 103B | |
+0.76% | 22.02B | |
-17.84% | 20.9B | |
-9.35% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B | |
-26.18% | 8.08B |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.
- Regeneron Pharmaceuticals : , AstraZeneca to Co-Develop, Commercialize New Small Molecule Medicines for Obesity